ArticleBMC pulmonary medicine2024

Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease.

Rohit Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.